ifosfamide has been researched along with dactinomycin in 207 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (6.76) | 18.7374 |
| 1990's | 62 (29.95) | 18.2507 |
| 2000's | 76 (36.71) | 29.6817 |
| 2010's | 40 (19.32) | 24.3611 |
| 2020's | 15 (7.25) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Vahlensieck, W; Weissbach, L | 1 |
| Bourlière, B; Devred, P; Faure, F; Gentet, JC; Panuel, M; Scheiner, C; Ternier, F | 1 |
| Bachelot, C; Baudain, P; Bost, M; Durand, C; Dyon, JF; Pasquier, D; Plantaz, D | 1 |
| Black, T; Estrada-Aguilar, J; Greenberg, H; Hvizdala, E; Morse, S; Schroer, K; Walling, A | 1 |
| Burgers, V; Coene, IJ; Hilgers, FJ; Marion, J; Schouwenburg, PF; Voûte, PA | 1 |
| Gedikoğlu, G; Zülfikar, B | 1 |
| Bonavina, L; Calabrò, F; Loy, M; Rea, F; Salmaso, R; Vigo, M | 1 |
| Bosl, GJ; Fair, W; Geller, NL; Herr, H; Morse, M; Motzer, RJ; Russo, P; Sheinfeld, J; Sogani, P; Tan, CC | 1 |
| Bachy, B; Caillaud, JM; Flamant, F; Gruner, M; Hemet, J; Lefur, R; Lemerle, J; Tron, P; Vannier, JP | 1 |
| Pinkerton, CR | 1 |
| Comoy, E; Flamant, F; McDowell, H; Niaudet, P; Suarez, A | 1 |
| Burgers, JM; Dunst, J; Hawliczek, R; Jürgens, H; Kürten, R; Müschenich, M; Salzer-Kuntschik, M; Sauer, R; Winkelmann, W | 1 |
| Iqbal, Z; Mallick, JA; Zaidi, SH | 1 |
| Gutjahr, P; Jürgens, H; Kühl, J; Kutzner, J; Ludwig, R; Michaelis, J; Niethammer, D; Schmidt, D; Schwenger, M; Spaar, HJ | 1 |
| Eschenbach, C; Maroske, D; Winkler, K | 1 |
| Bachy, B; Boillot, B; Borde, J; Hemet, J; Mitrofanoff, P; Vannier, JP | 1 |
| Brunat-Mentigny, M; Manoukian, A; Nourissat, C; Patricot, LM; Tachon, G | 1 |
| Exner, U; Göbel, U; Jürgens, H; Kühl, J; Ritter, J; Treuner, J; Weinel, P; Winkler, K | 1 |
| Brunat-Mentigny, M; Dutou, L; Flamant, F; Olive, D; Otten, J; Quintana, E; Rodary, C; Voûte, PA | 1 |
| Behar, C; Benz-Lemoine, E; Boilletot, A; Brunat-Mentigny, M; Deméocq, F; Gentet, JC; Oberlin, O; Olive, D; Poutard, P; Zucker, JM | 1 |
| Keim, M; Koscielniak, E; Treuner, J | 1 |
| Kaatsch, P; Keim, M; Niethammer, D; Suder, J; Treuner, J | 1 |
| Baume, D; Diallo, A; Fernandez, H; Papiernik, E | 1 |
| Akiyama, S; Ichihashi, H; Takagi, H | 1 |
| Akatchereian, C; Flamant, F; Ghosn, M; Salloum, E; Taleb, N | 1 |
| Delépine, G; Delépine, N; Desbois, JC; Legmann, F; Mathé, G | 1 |
| de Kraker, J; Voûte, PA | 1 |
| López Pérez, J; Melero, C; Muley, R; Torres Valdivieso, MJ; Vara, J; Vivanco, JL | 1 |
| Flamant, F; Gentet, JC; Quintana, E; Rousseau, P; Voute, PA | 1 |
| Broun, ER; Einhorn, LH; Lazarus, HM; Loehrer, PJ; Nichols, CR; Roth, BJ; Turns, M; Williams, SD | 1 |
| Carpentier, AF; Chantelard, JV; Henin, D; Poisson, M | 1 |
| Adam, G; Casser, HR; Füzesi, L; Schleicher, UM | 1 |
| Gehan, E; Maurer, H; Newton, WA; Ruymann, FB; Vietti, T; Wharam, M; Wiener, E | 1 |
| Dunst, J; Jürgens, H; Pape, H; Paulussen, M; Rübe, C; Sauer, R; Winkelmann, W | 1 |
| Barrenetxea, G; Centeno, MM; Pérez, C; Rodríguez-Escudero, FJ; Schneider, J; Tánago, JG | 1 |
| Flamant, F; Pein, F; Rialland, X; Saint-Andre, JP | 1 |
| Bielack, SS; Delling, G; Jürgens, H; Kotz, R; Salzer-Kuntschik, M; Winkler, K | 1 |
| Delepine, G; Delepine, N; Desbois, JC | 1 |
| Contesso, G; Edeline, V; Kalifa, C; Lemerle, J; Razafindrakoto, H; Valteau, D; Vanel, D; Vassal, G | 1 |
| Göthert, M; Herold, H; Szelenyi, I | 1 |
| Cohen, BJ; Miller, ST; Rao, SP | 1 |
| Bacci, G; Barbieri, E; Casadei, R; Fabbri, N; Ferrari, S; Ferraro, A; Mercuri, M; Picci, P; Rosito, P; Ruggieri, P | 1 |
| Dunst, J; Jürgens, H; Paulussen, M | 1 |
| Hamada, M; Inoue, H; Nakagawa, Y; Ozaki, T; Sugihara, S; Taguchi, K | 1 |
| Hibi, S; Imashuku, S; Kataoka, Y; Morimoto, M; Naya, M; Takaya, K; Todo, S | 1 |
| Craft, AW; Davies, SM; Jones, PH; King, DJ; Kynaston, JA; Malcolm, AJ; Mitchell, CD; Oakhill, A; Stiller, CA | 1 |
| Herrmann, C; Hiddemann, W; Meyer, T; Schauer, A | 1 |
| Bacci, G; Barbieri, E; Brach del Prever, A; Campanacci, M; Ferrari, S; Forni, C; Iantorno, D; Mercuri, M; Rosito, P | 1 |
| Finegold, MJ; Gunawardena, SW; Ogden, AK; Trautwein, LM | 1 |
| Hirao, Y; Kaneko, Y; Momose, H; Okajima, E; Ozono, S; Samma, S; Tsumatani, K; Watanabe, S; Yamada, K | 1 |
| Broun, ER; Cornetta, K; Einhorn, LH; Gize, G; Hromas, RA; Nichols, CR; Schacht, B | 1 |
| Lackner, H; Urban, C | 1 |
| Cheng, MY; Lee, AC; Wong, KW | 1 |
| Bacci, G; Barbieri, E; Brach Del Prever, A; Ferrari, S; Forni, C; Iantorno, D; Mercuri, M; Rosito, P; Ruggieri, P | 1 |
| Flentje, M; Graf, N; Ludwig, R; Pötter, R; Weirich, A; Zimmerman, H | 1 |
| Fink, FM; Heitger, A; Maurer, K; Niederweiser, D; Schwaighofer, H | 1 |
| Bacci, G; Barbieri, E; Brach del Prever, A; Ferrari, S; Forni, C; Mercuri, M; Picci, P; Rosito, P; Tienghi, A | 1 |
| Chan, HS; Doyle, J; Greenberg, ML; Karaskov, V; Koren, G; Malkin, D; Moncica, I; Theis, JG | 2 |
| Berghoff, R; Cédola, J; Drut, R; Pollono, DG; Tomarchio, S; Urrutia, A | 1 |
| Boglino, C; Boldrini, R; Ciprandi, G; Inserra, A; Zangari, A | 1 |
| Erman, O; Simşek, T; Trak, B; Uner, M; Zorlu, GC | 1 |
| Bladou, F; Delpero, JR; Merrot, T; Moutardier, V; Viens, P | 1 |
| Ahrens, S; Dunst, J; Harms, D; Jürgens, H; Paulussen, M; Rübe, C; Winkelmann, W; Zoubek, A | 1 |
| Barrett, A; Brunat-Mentigny, M; Flamant, F; Habrand, JL; Martelli, H; Oberlin, O; Otten, J; Praquin, MT; Quintana, E; Rey, A; Rodary, C; Sommelet, D; Terrier-Lacombe, MJ; Theobald, S; Voûte, PA | 1 |
| Ahrens, S; Dunst, J; Hillmann, A; Hofmann, J; Jürgens, H; Paulussen, M; Rübe, C; Schuck, A; Willich, N | 1 |
| Bacci, G; Barbieri, E; Cesari, M; Di Liddo, M; Ferrari, S; Longhi, A; Mancini, A; Mercuri, M; Rimondini, S; Rosito, P; Ruggieri, P | 1 |
| Bacci, G; Baldini, N; Barbieri, E; Cesari, M; Ferrari, S; Longhi, A; Mancini, AF; Mercuri, M; Picci, P; Rosito, P | 1 |
| Ahrens, S; Braun-Munzinger, G; Dunst, J; Göbel, U; Harms, D; Heinecke, A; Hoffmann, C; Jabar, S; Jürgens, H; Paulussen, M; Rübe, C; Treuner, J; Winkelmann, W; Winkler, K | 1 |
| Czyzewski, EA; Goldman, S; Hallahan, DE; Mundt, AJ; Nachman, J; Rubin, C | 1 |
| Bisogno, G; Carli, M; Cecchetto, G; D'Amore, ES; Roganovich, J | 1 |
| Gardner, RV; Shetty, AK; Warrier, RP; Yu, LC | 1 |
| Carli, M; Colombatti, R; Frascella, E; Koscielniak, E; Masiero, L; Oberlin, O; Pinkerton, CR; Stevens, M; Treuner, J | 1 |
| Gadner, H; Harms, D; Henze, G; Herbst, M; Jürgens, H; Klingebiel, T; Knietig, R; Koscielniak, E; Morgan, M; Schmidt, BF; Treuner, J | 1 |
| Bekradda, M; Bensmaïne, MA; Brain, E; Cvitkovic, E; Di Palma, M; Garrino, C; Goupil, A; Misset, JL; Soulié, P | 1 |
| Bacchini, P; Bacci, G; Bertoni, F; Donati, D; Ferrari, S; Forni, C; Longhi, A; Manfrini, M; Picci, P; Rimondini, S | 1 |
| Kinouchi, T; Kotake, T; Kuroda, M; Maeda, O; Meguro, N; Miki, T; Saiki, S; Usami, M | 1 |
| Ashley, S; Atra, A; Cannon, S; Cotterill, SJ; Craft, AW; Grimer, R; Lewis, I; Pinkerton, CR; Shankar, AG; Spooner, D | 1 |
| Bisogno, G; Carli, M; di Montezemolo, LC; Donfrancesco, A; Mascarin, M; Ninfo, V; Roganovich, J; Sotti, G | 1 |
| Anderson, JR; Baker, KS; Breneman, JC; Crist, WM; Grier, HE; Link, MP; Maurer, HM; Qualman, SJ; Wiener, ES | 1 |
| Caulfield, R; Eustace, S; Fennelly, DJ; Hurson, B; Kennedy, JG; O'Rourke, KS | 1 |
| Anthoney, A; de Bono, JS; Graham, J; Kaye, SB; Kirk, D; Paul, J; Simpson, A; Underwood, M | 1 |
| Moerman, PH; Scheidt, P; Vergote, I | 1 |
| Brandao, L; Cain, AM; Kun, LE; McCarville, MB; Pappo, AS; Poquette, CA; Spunt, SL | 1 |
| Ahrens, S; Amann, G; Dockhorn-Dworniczak, B; Dunst, J; Exner, GU; Gadner, H; Göbel, U; Harms, D; Janka-Schaub, G; Jürgens, H; Kornhuber, B; Kotz, R; Müller-Weihrich, S; Paulussen, M; Treuner, J; Voûte, PA; Welte, K; Winkelmann, W; Zoubek, A | 1 |
| Blair, IA; Felix, CA; Lo Nigro, L; Lovett, BD; Megonigal, MD; Nowell, PC; Osheroff, N; Rappaport, EF; Williams, WR; Zheng, N | 1 |
| Crooke, MJ; Delahunt, B; Lewis, ME; Pringle, KC; Wiltshire, EJ | 1 |
| Carlini, C; Gambini, C; Granata, C; Jasonni, V; Mattioli, G; Mazzola, C; Repetto, P; Torre, M | 1 |
| Cizmić, A; Milanovic, R; Pajić, A; Zganjer, M | 1 |
| Ahrens, S; Aulitzky, WE; Dunst, J; Fölsch, UR; Göbel, U; Harms, D; Hense, HW; Henze, G; Jürgens, H; Kremens, B; Lehnert, M; Niemeyer, C; Paulussen, M; Reiter, A; Taeger, D; Voûte, PA; Wagner, A; Zoubek, A | 1 |
| Anderson, JR; Barr, FG; Crist, WM; Donaldson, SS; Maurer, HM; Pappo, AS; Qualman, SJ; Raney, RB; Wiener, ES | 1 |
| Breitfeld, PP; Crist, WM; Donaldson, SS; Lobe, T; Lyden, E; Maurer, HM; Raney, RB; Ruymann, FB; Teot, LA; Wharam, M | 1 |
| Mihova, A; Mumdjiev, I; Sokolov, T; Stoianova, A | 1 |
| Ahrens, S; Dunst, J; Jürgens, H; Könemann, S; Paulussen, M; Rübe, C; Rübe, CE; Schuck, A; Willich, N | 1 |
| Casanova, M; Collini, P; Ferrari, A; Mazza, EA; Meazza, C; Podda, M | 1 |
| Georges, B; Janot, F; Luboinski, B; Oberlin, O; Quintana, E; Rozan, O; Schwaab, G; Tran Ba Huy, P | 1 |
| Seregard, S | 1 |
| Blütters-Sawatzki, R; Gossen, R; Neugebauer, M; Reiter, A; Woessmann, W | 1 |
| Hosoi, H; Iehara, T; Misawa, A; Sawada, T; Sugimoto, T; Tsuchiya, K | 1 |
| Daniele, RM; Minervini, C; Muggeo, P; Novielli, C; Rigillo, N; Surico, G | 1 |
| Dickman, PS; Donaldson, SS; Fryer, CJ; Gebhardt, MC; Grier, HE; Krailo, MD; Link, MP; Meyers, PA; Miser, JS; Moore, S; Perlman, EJ; Pritchard, DJ; Rausen, AR; Tarbell, NJ; Vietti, TJ | 2 |
| Bouvet, N; Godzinski, J; Martelli, H; Oberlin, O; Rey, A; Spicer, RD; Stevens, MC; Stewart, RJ | 1 |
| Chen, C; Goldwein, JW; Maity, A; Shu, HK; Womer, RB | 1 |
| Bechthold, S; Ehrt, O; Jung, A; Pfluger, T; Renner, C | 1 |
| Donner, LR; Teshima, I | 1 |
| Caruso, RA; Napoli, P; Starrantino, M; Villari, D | 1 |
| Amodeo, R; Anghel, G; De Rosa, L; Majolino, I; Pandolfi, A; Riccardi, M | 1 |
| Blütters-Sawatzki, R; Bohle, RM; Dreyer, T; Gruessner, SE; Omwandho, CO; Reiter, A; Tinneberg, HR | 1 |
| Goto, T; Hozumi, T; Kobayashi, H; Kondo, T; Kosaku, H | 1 |
| Billups, CA; Davidoff, AM; Krasin, MJ; Kun, LE; Merchant, TE; Neel, MD; Rodriguez-Galindo, C | 1 |
| Akansel, G; Arisoy, AE; Calişkan, M; Corapcioglu, F; Dillioğlugil, O; Sarper, N | 1 |
| Ishizaka, K; Kobayashi, S; Kobayashi, T; Machida, T; Oka, K; Oka, T; Ozeki, Z | 1 |
| Sugiura, H; Suzuki, Y; Takahashi, M; Yamada, K | 1 |
| Bouvet, N; Ellershaw, C; Flamant, F; Habrand, JL; Marsden, HB; Martelli, H; Oberlin, O; Rey, A; Sanchez de Toledo, J; Spicer, RD; Spooner, D; Stevens, MC; Terrier-Lacombe, MJ; van Unnik, A | 1 |
| Alaggio, R; Bergeron, C; Bisogno, G; Carli, M; Casanova, M; D'Angelo, P; Di Cataldo, A; Ferrari, A; Prete, A; Scagnellato, A | 1 |
| Argenta, PA; Dusenbery, KE; Judson, PL; Potish, RA | 1 |
| Billups, CA; Davidoff, AM; Fuller, CE; Krasin, MJ; Merchant, TE; Neel, MD; Rodriguez-Galindo, C | 1 |
| Burger, CW; Ewing, P; Seynaeve, C; Snijders-Keilholz, A | 1 |
| Abelairas Gómez, JM; Calvo, JM; Olivier Pascual, N | 1 |
| Oberlin, O; Orbach, D; Quintana, E; Rey, A; Sanchez de Toledo, J; Stevens, MC; Terrier-Lacombe, MJ; van Unnik, A | 1 |
| Beane, C; Boddy, AV; Brennan, B; Chisholm, JC; Cole, M; Elsworth, AM; Errington, J; Glaser, A; Hale, J; Hemsworth, S; Howe, K; Jenner, G; McDowell, H; Nicholson, J; Parry, A; Pearson, AD; Pinkerton, R; Pritchard-Jones, K; Veal, GJ; Waters, F; Wright, Y | 1 |
| Lasorella, G; Loffredo, A; Pichierri, P; Polito, E | 1 |
| Bisogno, G; Casale, F; Cecchetto, G; De Salvo, G; Di Martino, M; Di Tullio, MT; Donfrancesco, A; Donofrio, V; Ferrari, A; Indolfi, P; Martone, A | 1 |
| Constantinidis, J; Dimmler, A; Iro, H; Koch, M; Strauss, C | 1 |
| Buurman, WA; Derikx, JP; Granzen, B; Heineman, E; van Bijnen, AA; van Waardenburg, DA | 1 |
| Mai, WY; Nguyen, TX; Paulino, AC; Teh, BS; Wen, BC | 1 |
| Bisogno, G; Carli, M; Casanova, M; Ferrari, A; Meazza, C; Zanetti, I | 1 |
| Katski, K; Kołłataj, B; Kołłataj, W; Majewski, M; Pijanowska, M; Sikora, P; Zajaczkowska, M | 1 |
| Bernstein, M; Chen, Z; Donaldson, SS; Fryer, CJ; Gebhardt, MC; Grier, HE; Krailo, M; Laurie, F; Miser, JS; Tarbell, NJ; Yock, TI | 1 |
| Anderson, J; Meyer, WH; Meza, JL; Pappo, AS | 1 |
| Askin, FB; Bhatia, S; Burden, L; Chen, Z; Dickman, PS; Grier, HE; Krailo, MD; Link, MP; Meyers, PA; Miser, JS; Perlman, EJ; Rausen, AR; Robison, LL; Vietti, TJ | 1 |
| Kawakami, M; Kawase, K; Kobayashi, T; Morikawa, T; Nogi, H; Suzuki, M; Tabei, I; Toriumi, Y; Uchida, K | 1 |
| Han, SY; Jang, JS; Jeong, JS; Kim, KT; Lee, SW; Park, EH; Roh, MH | 1 |
| Beck, JD; Bielack, S; Bölling, T; Dörr, HG; Jürgens, H; Klingebiel, T; Koscielniak, E; Langer, T; Paulides, M; Sauer, R; Stöhr, W; Willich, N | 1 |
| Boven, E; Meijer, OW; Smorenburg, CH; van Groeningen, CJ; Visser, M | 1 |
| Breslow, NE; Feusner, JH; Green, DM; Norkool, PA; Ritchey, ML; Takashima, JR | 1 |
| Belinelli, D; Iusco, D; Negri, L; Talarico, F | 1 |
| Goto, T; Hozumi, T; Kondo, T; Nakada, I; Okuma, T | 1 |
| Beske, F; Boos, J; Dantonello, T; Gadner, H; Hallmen, E; Int-Veen, C; Kazanowska, B; Klingebiel, T; Koscielniak, E; Marky, I; Treuner, J | 1 |
| Affolter, A; Ahmed, M; Marais, R; Nutting, CM; Pritchard-Jones, K; Sharma, AK; Thomas, V; Venkitaraman, R | 1 |
| Cassoni, A; Craft, AW; Douglas, C; Dunst, J; Grimer, R; Hackshaw, A; Hunold, A; Jürgens, H; Köhler, G; Ladenstein, R; Lewis, I; McTiernan, A; Paulussen, M; Poremba, C; Schuck, A; Spooner, D; van den Berg, H; Whelan, J; Winkelmann, W; Zoubek, A | 1 |
| Daw, NC; Gregornik, D; Jenkins, JJ; Jones, DP; Kun, LE; Marina, N; McPherson, V; Rodman, J; Wilimas, J; Wu, J | 1 |
| Kim, KJ; Kim, YD; Lee, YH | 1 |
| Bielack, SS; Brecht, I; Dantonello, TM; Dickerhoff, R; Gadner, H; Greiner, J; Greulich, M; Harms, D; Herbst, M; Int-Veen, C; Juergens, H; Kirsch, S; Klingebiel, T; Koscielniak, E; Leuschner, I; Marky, I; Scheel-Walter, HG; Schmelzle, R; Schmidt, BF; Treuner, J | 1 |
| Arndt, CA; Bernstein, M; Devidas, M; Dickman, P; Gebhardt, M; Goorin, A; Granowetter, L; Grier, HE; Healey, J; Krailo, M; Leavey, P; Marcus, K; Marina, N; Meyer, J; Miser, J; Perlman, E; Sailer, S; Shamberger, RC; Wang, C; Womer, R | 1 |
| DuBois, SG; Grier, HE | 1 |
| Heinen, RC; Merks, JH; van den Berg, H; van der Pal, HJ | 1 |
| Bacci, G; Balladelli, A; Briccoli, A; Di Fiore, M; Ferrari, C; Palmerini, E; Rocca, M; Salone, M | 1 |
| Bölling, T; Dirksen, U; Ernst, I; Jürgens, H; Ranft, A; Willich, N | 1 |
| Pappo, A; Paulino, AC | 1 |
| Ben Arush, MW; Doweck, I; Kuten, A; Postovsky, S; Shendler, Y; Vlodavsky, E | 1 |
| Bacin, F; Barthelemy, I; Bonnin, N; Dauplat, MM; Demeocq, F; Gabrillargues, J; Nezzar, H; Viennet, A | 1 |
| Croué, A; Pavageau, AH; Reguerre, Y; Rialland, X; Rousselet, MC | 1 |
| Ajarim, D; Al Dayel, F; Allam, A; Bazarbashi, S; El Weshi, A; Memon, M; Pant, R | 1 |
| Craft, A; Dirksen, U; Hjorth, L; Jürgens, H; Ladenstein, R; Le Deley, MC; Lewis, I; Michon, J; Oberlin, O; Paulussen, M; Pötschger, U; van den Berg, H; Whelan, J | 1 |
| El-Baz, M; Ghali, AM; Ghoneim, MA; Sarhan, MM; Sarhan, OM | 1 |
| Alberghini, M; Alvegard, TA; Bacci, G; Barbieri, E; Brach Del Prever, A; Capanna, R; Carli, M; Fagioli, F; Ferrari, S; Gandola, L; Luksch, R; Mapelli, S; Mercuri, M; Picci, P; Prete, A; Smeland, S; Sundby Hall, K; Tamburini, A; Tienghi, A; Wiebe, T | 1 |
| Kumabe, T; Niizuma, H; Osawa, S; Saito, R; Sonoda, Y; Tominaga, T; Watanabe, M | 1 |
| Harvey, R; Mitchell, H; Savage, P; Schmid, P; Seckl, M; White, S | 1 |
| Cho, J; Cho, WH; Jeon, DG; Kim, DH; Kim, MS; Koh, JS; Kong, CB; Lee, JA; Lee, SY; Lim, JS; Song, WS; Yoo, JY | 1 |
| Delaplace, M; Goré, C; Machet, L; Mélard, P; Perrinaud, A; Vergier, B | 1 |
| Anderson, JR; Dasgupta, R; Gupta, AA; Hawkins, DS; Indelicato, DJ; Pappo, AS; Spunt, SL | 1 |
| Raveesunthornkiet, M; Ruangtrakool, R; Sanpaki, K; Thorner, PS; Treetipsatit, J | 1 |
| Sarnaik, SA; Savaşan, S | 1 |
| Colpan Oksuz, D; Dervisoglu, S; Hiz, M; Kantarci, F; Koca, S; Molinas Mandel, N; Oner Dincbas, F; Selcukbiricik, F; Tural, D; Turna, H | 1 |
| Bergeron, C; Bouvet, N; Ellershaw, C; Jenney, ME; Kelsey, A; Martelli, H; Merks, JH; Oberlin, O; Rey, A; Sanchez de Toledo, J; Scopinaro, M; Spooner, D; Stevens, MC | 1 |
| Ash, S; Cohen, IJ; Feinmesser, M; Kornreich, L; Kuperman, AA; Yaniv, I | 1 |
| Andersen, CY; Birkebæk, NH; Clausen, N; Ernst, E; Kjærsgaard, M | 1 |
| Ellinger, J; Fechner, G; Goltz, D; Latz, S; Leuschner, I; Marx, C; Müller, SC | 1 |
| Amesty, MV; Chenu, BG; Chocarro, G; Gámez, M; Hernández, F; Hernández, S; Ortíz, R; Sánchez, A; Santamaría, ML; Tovar, JA | 1 |
| Angioi, K; Batta, B; Cloché, V; George, JL; Trechot, F | 1 |
| Heij, HA; Merks, JH; Spronk, P; Terwisscha van Scheltinga, CE; van Baren, R; van Noesel, MM; van Rosmalen, J; Wijnen, MH; Wijnen, RM | 1 |
| Cormenzana, M; García-Esparza, E; Hernández-Marqués, C; Lassaletta, A; Madero-López, L | 1 |
| Brennan, B; Craft, A; Dirksen, U; Hjorth, L; Judson, I; Juergens, H; Ladenstein, R; Le Deley, MC; Le Teuff, G; Lewis, I; Marec-Bérard, P; Michon, J; Oberlin, O; Paulussen, M; Ranft, A; van den Berg, H; Wheatley, K; Whelan, J | 1 |
| Bilska, K; Chaber, R; Drabko, K; Pogorzała, M; Połczyńska, K; Raciborska, A; Rodriguez-Galindo, C; Rogowska, E; Sobol, G; Wożniak, W; Wyrobek, E | 1 |
| Boutroux, H; Cellier, C; Desjardins, L; Freneaux, P; Helfre, S; Levy, C; Michon, J; Mosseri, V; Orbach, D; Plancher, C | 1 |
| Agarwala, S; Bakhshi, S; Biswas, B; Deo, SV; Khan, SA; Mohanti, BK; Rastogi, S; Sharma, MC; Shukla, NK; Vishnubhatla, S | 1 |
| Engert, F; Fulda, S; Probst, M; Schneider, C; Weiβ, LM | 1 |
| Aoki, Y; Araki, N; Hamada, K; Imura, Y; Joyama, S; Kakunaga, S; Naka, N; Obata, H; Takenaka, S; Ueda, T; Yoshikawa, H | 1 |
| Bas-Bernal, A; Bermúdez-Cortés, M; Doménech-Abellán, E; Fita, AM; Fuster-Soler, JL; Galera-Miñarro, AM; Llinares-Riestra, E | 1 |
| Arndt, CAS; Bisogno, G; Koscielniak, E | 1 |
| Abadjian, G; Abi-Tayeh, G; Assi, T; Eid, R; El Rassy, E; Farhat, F; Kattan, J; Moussa, T; Sader-Ghorra, C | 1 |
| Berbegall, AP; Blanquer-Maceíras, MT; Ferrández, A; Machado, I; Martinez-Ciarpaglini, C; Navarro, S; Nieto, G; Noguera, R; Yoshida, A | 1 |
| Adamkiewicz-Drozynska, E; Bien, E; Fatyga, A; Gabrych, A; Izycka-Swieszewska, E; Kazanowska, B; Krawczyk, MA; Kunc, M; Sokolewicz, EM; Styczewska, M | 1 |
| Bergamaschi, L; Bertulli, R; Casanova, M; Chiaravalli, S; Collini, P; Diletto, B; Ferrari, A; Fiore, M; Gandola, L; Gasparini, P; Massimino, M; Morosi, C; Provenzano, S; Sangalli, C | 1 |
| Khalifeh, I; Maroun, CA; Moukarbel, RV; Tfayli, A | 1 |
| Calvão, J; Cardoso, JC; Figueiredo, A; Ramos, L | 1 |
| Anderton, J; Brennan, B; Evans, A; Fenwick, N; Fernández-Pinto, M; Gaspar, N; Gelderblom, H; Kaiser, S; Laurence, V; Marec-Bérard, P; Martín-Broto, J; Moroz, V; Owens, C; Sastre, A; Strauss, S; Wheatley, K; Whelan, J | 1 |
| Bisogno, G; Hawkins, DS | 1 |
| Al-Rohil, RN; Bentley, RC; Cardona, DM; Feng, X; Jour, G; Shen, G; Underwood, CIM | 1 |
| Bergamaschi, L; Casanova, M; Chiaravalli, S; Ferrari, A; Pascale, S; Recupero, S; Zecca, M | 1 |
| Barthère, X; Guillerm, S; Hennequin, C; Itti, R; Le Maignan, C; Quero, L; Torossian, N; Verillaud, B | 1 |
| Hua, Q; Xu, G; Zhang, T; Zhao, L | 1 |
| Bergeron, C; Bisogno, G; Chisholm, J; De Corti, F; De Salvo, GL; Ferrari, A; Gallego, S; Glosli, H; Jenney, M; Merks, H; Minard-Colin, V; Ranchère-Vince, D; Rogers, T; Zanetti, I | 1 |
| Alessandro, O; Bergamaschi, L; Casanova, M; Chiaravalli, S; Diletto, B; Ferrari, A; Giandini, T; Livellara, V; Pecori, E; Sironi, G | 1 |
| Donaldson, SS; Hazard, FK; Hiniker, SM; Hui, C; Rangaswami, A; Shin, DH; Wakeling, A | 1 |
| Al-Saadi, R; Brok, J; de Camargo, B; de Krijger, RR; Drost, J; Godzinski, J; Graf, N; Groenendijk, A; Jiang, Y; Mavinkurve-Groothuis, AMC; Morosi, C; Perotti, D; Pritchard-Jones, K; Ramírez-Villar, GL; Rübe, C; Schenk, JP; Spreafico, F; Vaidya, SJ; van den Heuvel-Eibrink, MM; van Tinteren, H; Verschuur, AC; Vujanic, GM | 1 |
| Alaggio, R; Bisogno, G; Casanova, M; Cecchetto, G; Ferrari, A; Kazanowska, B; Klingebiel, T; Koscielniak, E; Kosztyla, D; Ladenstein, R; Ljungman, G; Milano, GM; Niggli, F; Scarzello, G; Sparber-Sauer, M; Vokuhl, C; Zin, A | 1 |
| Ben-Arush, M; Bisogno, G; Cameron, AL; Casanova, M; Chisholm, JC; Coppadoro, B; Elze, M; Ferman, S; Ferrari, A; Gallego, S; Geoerger, B; Guizani, C; Jenney, M; Kelsey, A; McHugh, K; Merks, JHM; Minard-Colin, V; Orbach, D; Rogers, T; Schoot, RA; van Rijn, RR; Zanetti, I | 1 |
| Bompas, E; Brugières, L; Castex, MP; Chevreau, C; Cleirec, M; Corvest, V; Duranteau, L; Entz-Werle, N; Filhon, B; Flandrin, J; Fresneau, B; Gaspar, N; Gentet, JC; Guimard, G; Jimenez, M; Laurence, V; Le Deley, MC; Lervat, C; Mansuy, L; Marec-Bérard, P; Pacquement, H; Pondrom, M; Rousset-Jablonski, C; Saumet, L; Tabone, MD; Taque, S; Toulmonde, M; Verité, C | 1 |
| Brennan, B; Fenwick, N; Gaspar, N; Gelderblom, H; Kirton, L; Laurence, V; Marec-Bérard, P; Martín-Broto, J; Moroz, V; Owens, C; Sastre, A; Strauss, S; Wheatley, K; Whelan, J | 1 |
23 review(s) available for ifosfamide and dactinomycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Megatherapy for soft tissue sarcomas. EBMT experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Drug; Drug Therapy; Europe; Humans; Ifosfamide; Sarcoma; Soft Tissue Neoplasms; Vincristine; Whole-Body Irradiation | 1991 |
Translocation t(11;19) (q23;p13) in a child with myelomonocytic leukemia following 2 years after chemotherapy for pneumoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 19; Dactinomycin; Humans; Ifosfamide; Leukemia, Myelomonocytic, Acute; Lung Neoplasms; Male; Neoplasms, Second Primary; Translocation, Genetic; Vincristine | 1993 |
Treatment of osteosarcoma: experience of the Cooperative Osteosarcoma Study Group (COSS).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Clinical Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Germany; Humans; Ifosfamide; Immunologic Factors; Interferon-beta; Methotrexate; Multicenter Studies as Topic; Osteosarcoma; Prognosis; Randomized Controlled Trials as Topic; Treatment Outcome; Vincristine | 1993 |
Paratesticular desmoplastic small round cell tumor: case report and review of the literature.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Dactinomycin; Genital Neoplasms, Male; Humans; Ifosfamide; Male; Scrotum; Urologic Surgical Procedures, Male; Vincristine | 1999 |
Extraskeletal Ewing's sarcoma: a case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cervical Vertebrae; Combined Modality Therapy; Dactinomycin; Doxorubicin; Humans; Ifosfamide; Laminectomy; Male; Radiotherapy; Sarcoma, Ewing; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2000 |
Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infant; Male; Melphalan; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Rhabdomyosarcoma; Salvage Therapy; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Topotecan; Treatment Outcome; Vincristine | 2001 |
Successful chemotherapy for melanotic neuroectodermal tumor of infancy in a baby.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Daunorubicin; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Male; Maxillary Neoplasms; Neuroectodermal Tumor, Melanotic; Treatment Outcome; Vinca Alkaloids | 2003 |
Volumetric considerations in radiotherapy for pediatric parameningeal rhabdomyosarcomas.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Ifosfamide; Life Tables; Male; Nasopharyngeal Neoplasms; Neoplasm Staging; Pennsylvania; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Retrospective Studies; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Survival Analysis; Treatment Outcome; Vincristine | 2003 |
Orbital rhabdomyosarcoma in Noonan syndrome.
Topics: Brachytherapy; Child; Combined Modality Therapy; Dactinomycin; Exophthalmos; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Neoplastic Syndromes, Hereditary; Noonan Syndrome; Orbital Neoplasms; Radioisotope Teletherapy; Rhabdomyosarcoma, Embryonal; Vincristine | 2003 |
Management of stage I cervical sarcoma botryoides in childhood and adolescence.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child, Preschool; Dactinomycin; Female; Humans; Ifosfamide; Neoplasm Staging; Rhabdomyosarcoma, Embryonal; Uterine Cervical Neoplasms; Vincristine | 2004 |
[Soft tissue sarcoma: postoperative chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Administration Schedule; Humans; Ifosfamide; Melphalan; Mesna; Methotrexate; Osteosarcoma; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 2004 |
On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus.
Topics: Abdominal Neoplasms; Antineoplastic Agents; Brachytherapy; Chemotherapy, Adjuvant; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Humans; Hysterectomy; Ifosfamide; Intestinal Obstruction; Leiomyosarcoma; Life Tables; Mixed Tumor, Mullerian; Neoplasm Staging; Pelvic Neoplasms; Peritoneal Neoplasms; Radiation Injuries; Radiotherapy, Adjuvant; Retrospective Studies; Sarcoma; Survival Analysis; Survival Rate; Treatment Failure; Uterine Neoplasms | 2005 |
Primitive neuroectodermal tumor of the cervix uteri: a case report -- changing concepts in therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Mesna; Neoadjuvant Therapy; Neuroectodermal Tumors, Primitive, Peripheral; Uterine Cervical Neoplasms; Vincristine | 2005 |
[Orbital rhabdomyosarcoma: difficulties with European treatment protocol].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Clinical Protocols; Combined Modality Therapy; Cranial Irradiation; Dactinomycin; Disease-Free Survival; Epirubicin; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Life Tables; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Orbital Neoplasms; Radiation Injuries; Radiotherapy, Adjuvant; Reoperation; Rhabdomyosarcoma, Embryonal; Survival Analysis; Treatment Outcome; Vincristine | 2005 |
Combined resection and multi-agent adjuvant chemotherapy for intra-abdominal desmoplastic small round cell tumour: case report and review of the literature.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Dactinomycin; Doxorubicin; Fibromatosis, Aggressive; Humans; Ifosfamide; Male; Retroperitoneal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2007 |
Bilateral Wilms' tumors: single-center experience with 22 cases and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Doxorubicin; Egypt; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Mesna; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Nephrectomy; Retrospective Studies; Treatment Outcome; Vincristine; Wilms Tumor | 2010 |
[Vincristine-induced unilateral ptosis: case report and review of the literature].
Topics: Antineoplastic Combined Chemotherapy Protocols; Blepharoptosis; Child, Preschool; Dactinomycin; Female; Humans; Ifosfamide; Rhabdomyosarcoma; Vaginal Neoplasms; Vincristine | 2013 |
Fifty years of rhabdomyosarcoma studies on both sides of the pond and lessons learned.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Dactinomycin; Europe; Humans; Ifosfamide; Internationality; North America; Randomized Controlled Trials as Topic; Rhabdomyosarcoma; Soft Tissue Neoplasms; Vincristine | 2018 |
Chemotherapy-induced differentiation to cure botryoid rhabdomyosarcoma: a case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Dactinomycin; Desmin; Female; Humans; Ifosfamide; Immunohistochemistry; Magnetic Resonance Imaging; Myogenin; Rhabdomyosarcoma; Tomography, X-Ray Computed; Uterine Neoplasms; Vincristine | 2017 |
Primary Ewing sarcoma of the larynx with distant metastasis: a case report and review of the literature.
Topics: Antineoplastic Agents; Bone Neoplasms; Chemoradiotherapy; Cyclophosphamide; Dactinomycin; Etoposide; Fluorodeoxyglucose F18; Humans; Ifosfamide; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Sarcoma, Ewing; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2019 |
Adult parameningial alveolar rhabdomyosarcoma: Case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Combined Modality Therapy; Dactinomycin; Doxorubicin; Female; Humans; Ifosfamide; Middle Aged; Nose Neoplasms; Radiotherapy, Intensity-Modulated; Rhabdomyosarcoma, Alveolar; Vincristine | 2020 |
Effect of anthracyclines/ifosfamide-based adjuvant chemotherapy for soft tissue sarcoma: a conventional and network Meta-analysis.
Topics: Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Chemotherapy, Adjuvant; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Ifosfamide; Neoplasm Recurrence, Local; Network Meta-Analysis; Sarcoma; Survival Analysis; Vincristine | 2021 |
51 trial(s) available for ifosfamide and dactinomycin
| Article | Year |
|---|---|
Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Follow-Up Studies; Genital Neoplasms, Male; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Remission Induction; Survival Analysis; Survival Rate; Vinblastine | 1991 |
Radiation therapy as local treatment in Ewing's sarcoma. Results of the Cooperative Ewing's Sarcoma Studies CESS 81 and CESS 86.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Europe; Humans; Ifosfamide; Radiotherapy Dosage; Sarcoma, Ewing; Vincristine | 1991 |
Ifosfamide in soft tissue sarcoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Mesna; Sarcoma; Soft Tissue Neoplasms | 1990 |
Treatment of rhabdomyosarcoma and other malignant mesenchymal tumours of childhood with ifosfamide + vincristine + dactinomycin (IVA) as front-line therapy (a SIOP study).
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Dactinomycin; Humans; Ifosfamide; Mesenchymoma; Rhabdomyosarcoma; Vincristine | 1989 |
Initial chemotherapy including ifosfamide in the management of Ewing's sarcoma: preliminary results. A protocol of the French Pediatric Oncology Society (SFOP).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Dactinomycin; Doxorubicin; France; Humans; Ifosfamide; Medical Oncology; Pediatrics; Remission Induction; Sarcoma, Ewing; Societies, Medical; Vincristine | 1989 |
Comparison of the rates of response to ifosfamide and cyclophosphamide in primary unresectable rhabdomyosarcomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Ifosfamide; Remission Induction; Rhabdomyosarcoma; Soft Tissue Neoplasms; Vincristine | 1989 |
Primary chemotherapy in rhabdomyosarcomas and other malignant mesenchymal tumors of the orbit: results of the International Society of Pediatric Oncology MMT 84 Study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dactinomycin; Humans; Ifosfamide; Infant; Mesenchymoma; Neoplasm Recurrence, Local; Neoplasm Staging; Orbital Neoplasms; Prospective Studies; Rhabdomyosarcoma; Salvage Therapy; Survival Analysis; Treatment Outcome; Vincristine | 1994 |
Cyclophosphamide dose escalation in combination with vincristine and actinomycin-D (VAC) in gross residual sarcoma. A pilot study without hematopoietic growth factor support evaluating toxicity and response.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Drug; Female; Hematopoietic Cell Growth Factors; Humans; Ifosfamide; Infant; Male; Pilot Projects; Recurrence; Rhabdomyosarcoma; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1995 |
Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Ifosfamide; Male; Radiotherapy Dosage; Sarcoma, Ewing; Treatment Failure; Vincristine | 1995 |
Chemotherapy in osteogenic sarcoma: the experience of the Pediatric Department of the Gustave Roussy Institute.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Feasibility Studies; Female; France; Humans; Ifosfamide; Leucovorin; Male; Methotrexate; Osteosarcoma; Survival Rate; Treatment Outcome; Vincristine | 1993 |
No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Middle Aged; Prognosis; Remission Induction; Sarcoma, Ewing; Vincristine | 1993 |
[Clinical study of testicular cancer].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Germinoma; Humans; Ifosfamide; Lymph Node Excision; Male; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Radiotherapy; Survival Rate; Vinblastine | 1996 |
Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Injections, Intravenous; Male; Neoplasm Recurrence, Local; Sarcoma, Ewing; Vincristine | 1998 |
Increased systemic toxicity of sarcoma chemotherapy due to combination with the P-glycoprotein inhibitor cyclosporin.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Child; Cyclophosphamide; Cyclosporine; Dactinomycin; Drug Interactions; Etoposide; Fever; Humans; Ifosfamide; Immunosuppressive Agents; Neutropenia; Patient Admission; Retrospective Studies; Sarcoma; Sepsis; Soft Tissue Neoplasms; Vincristine | 1998 |
Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dactinomycin; Female; Head and Neck Neoplasms; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Quality of Life; Rhabdomyosarcoma; Treatment Outcome; Urogenital Neoplasms; Vincristine | 1998 |
Radiotherapy in Ewing's sarcoma and PNET of the chest wall: results of the trials CESS 81, CESS 86 and EICESS 92.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Neuroectodermal Tumors, Primitive, Peripheral; Retrospective Studies; Sarcoma, Ewing; Thorax; Vincristine | 1998 |
Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Humans; Ifosfamide; Male; Neoadjuvant Therapy; Prognosis; Sarcoma, Ewing; Vincristine | 1998 |
Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone: the CESS 86 experience. Cooperative Ewing Sarcoma Study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Ifosfamide; Male; Multivariate Analysis; Neoplasm Staging; Prognosis; Proportional Hazards Models; Regression Analysis; Sarcoma, Ewing; Survival Analysis; Vincristine | 1999 |
Role of chemotherapy in the treatment of infantile fibrosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fibrosarcoma; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Mesna; Soft Tissue Neoplasms; Vincristine | 1999 |
High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cell Transplantation; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Epirubicin; Humans; Ifosfamide; Infant; Melphalan; Prospective Studies; Rhabdomyosarcoma; Treatment Outcome; Vincristine | 1999 |
Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Humans; Ifosfamide; Male; Outcome Assessment, Health Care; Preoperative Care; Prognosis; Recurrence; Research Design; Salvage Therapy; Sarcoma; Vincristine | 1999 |
Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Dactinomycin; Drug Resistance, Neoplasm; Drug Therapy, Combination; Epirubicin; Etoposide; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Salvage Therapy; Testicular Neoplasms; Thrombocytopenia; Treatment Outcome; Vinblastine; Vinorelbine | 1999 |
[Results of chemotherapy and salvage surgery for advanced testicular cancer].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Remission Induction; Salvage Therapy; Seminoma; Testicular Neoplasms; Vinblastine | 1999 |
Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease Progression; Disease-Free Survival; Etoposide; Female; Head and Neck Neoplasms; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Neoplasm Staging; Prognosis; Retrospective Studies; Rhabdomyosarcoma, Embryonal; Risk Factors; Vincristine | 2000 |
Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Europe; Humans; Ifosfamide; Incidence; Infant; Middle Aged; Neoplasms, Second Primary; Prospective Studies; Radiotherapy Dosage; Sarcoma, Ewing; Vincristine | 2001 |
Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bronchiolitis Obliterans; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kidney Diseases; Life Tables; Male; Melphalan; Neoplasm Metastasis; Radiotherapy, Adjuvant; Remission Induction; Rhabdomyosarcoma; Sepsis; Soft Tissue Neoplasms; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Neuroectodermal Tumors, Primitive; Prognosis; Sarcoma; Sarcoma, Ewing; Survival Rate; Treatment Failure; Vincristine | 2003 |
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Neoplasm Metastasis; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Dactinomycin; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Rhabdomyosarcoma; Teniposide; Treatment Outcome; Vincristine | 2005 |
The IVADo regimen--a pilot study with ifosfamide, vincristine, actinomycin D, and doxorubicin in children with metastatic soft tissue sarcoma: a pilot study of behalf of the European pediatric Soft tissue sarcoma Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Humans; Ifosfamide; Infant; Male; Pilot Projects; Risk Factors; Sarcoma; Vincristine | 2005 |
Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Humans; Ifosfamide; Infant; Infant, Newborn; Neoplasm Metastasis; Neoplasm Recurrence, Local; Rhabdomyosarcoma; Sarcoma; Survival Analysis; Teniposide; Vincristine | 2005 |
Pharmacokinetics of dactinomycin in a pediatric patient population: a United Kingdom Children's Cancer Study Group Study.
Topics: Adolescent; Adult; Analysis of Variance; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Area Under Curve; Child; Child, Preschool; Chromatography, Liquid; Dactinomycin; Dose-Response Relationship, Drug; Female; Fever; Humans; Ifosfamide; Infections; Infusions, Intravenous; Male; Mass Spectrometry; Metabolic Clearance Rate; Neoplasms; Time Factors | 2005 |
Full-dose ifosfamide can be safely administered to outpatients.
Topics: Adolescent; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dactinomycin; Dose-Response Relationship, Drug; Humans; Ifosfamide; Infant; Mesna; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Vincristine | 2008 |
Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Confounding Factors, Epidemiologic; Cyclophosphamide; Dactinomycin; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Pelvic Bones; Radiotherapy, Adjuvant; Sarcoma, Ewing; Treatment Outcome; Vincristine | 2006 |
Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infant; Infusions, Intravenous; Male; Neoplasm Staging; Predictive Value of Tests; Prognosis; Rhabdomyosarcoma; Risk Assessment; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 2006 |
Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Incidence; Infant; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Neural Tube Defects; Neuroectodermal Tumors, Primitive; Proportional Hazards Models; Risk; Sarcoma, Ewing; Vincristine | 2007 |
Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Epirubicin; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Melphalan; Sarcoma; Soft Tissue Neoplasms; Thiotepa; Treatment Outcome; Vincristine | 2008 |
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hematologic Diseases; Humans; Ifosfamide; Infant; Lung Neoplasms; Male; Neoplasm Staging; Prospective Studies; Sarcoma, Ewing; Vincristine | 2008 |
Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Dose Fractionation, Radiation; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Sarcoma, Synovial; Soft Tissue Neoplasms; Vincristine; Young Adult | 2009 |
Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 2009 |
Chemotherapy: The role of ifosfamide and etoposide in Ewing sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Neoplasm Metastasis; Radiography; Sarcoma, Ewing; Time Factors; Treatment Outcome; Tumor Burden; Vincristine | 2009 |
Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Infant; Middle Aged; Prognosis; Risk Factors; Sarcoma, Ewing; Vincristine | 2010 |
Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Busulfan; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Melphalan; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Sarcoma, Ewing; Vincristine; Young Adult | 2011 |
Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatr
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Dactinomycin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Male; Prognosis; Rhabdomyosarcoma; Sarcoma; Treatment Outcome; Vincristine | 2012 |
Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Consolidation Chemotherapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Sarcoma, Ewing; Treatment Outcome; Vincristine; Young Adult | 2014 |
International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours - EURO EWING 2012 Protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Busulfan; Child; Child, Preschool; Consolidation Chemotherapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Induction Chemotherapy; Male; Middle Aged; Sarcoma, Ewing; Vincristine; Young Adult; Zoledronic Acid | 2020 |
An unresolved issue in rhabdomyosarcoma treatment: The duration of chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Rhabdomyosarcoma; Survival Rate; Time Factors; Vincristine | 2020 |
Long-term results from the multicentric European randomized phase 3 trial CWS/RMS-96 for localized high-risk soft tissue sarcoma in children, adolescents, and young adults.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Dactinomycin; Doxorubicin; Humans; Ifosfamide; Rhabdomyosarcoma; Rhabdomyosarcoma, Embryonal; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine; Young Adult | 2022 |
Metastatic Rhabdomyosarcoma: Results of the European
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Humans; Ifosfamide; Neoplasms, Second Primary; Rhabdomyosarcoma; Sarcoma; Vincristine | 2022 |
Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; France; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Sarcoma, Ewing; Vincristine | 2023 |
Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Bone Neoplasms; Busulfan; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Melphalan; Sarcoma, Ewing; Vincristine | 2022 |
133 other study(ies) available for ifosfamide and dactinomycin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
The combined surgical and chemotherapeutic approach to non-seminomatous cancer of the testicle.
Topics: Chlorambucil; Dactinomycin; Drug Therapy, Combination; Dysgerminoma; Humans; Ifosfamide; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Postoperative Complications; Prognosis; Retroperitoneal Space; Teratoma; Testicular Neoplasms | 1977 |
[Rhabdoid tumor of the neck].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Combined Modality Therapy; Dactinomycin; Head and Neck Neoplasms; Humans; Ifosfamide; Infant; Male; Rhabdomyoma; Tomography, X-Ray Computed; Ultrasonography; Vincristine | 1992 |
[Parameningeal cervical rhabdomyosarcoma in the neonatal period].
Topics: Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Female; Head and Neck Neoplasms; Humans; Ifosfamide; Infant; Magnetic Resonance Imaging; Radiography; Rhabdomyosarcoma; Vincristine | 1992 |
Primary treatment of pelvic osteosarcoma. Report of five cases.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Fluid Therapy; Follow-Up Studies; Humans; Ifosfamide; Injections, Intra-Arterial; Lung Neoplasms; Osteosarcoma; Pelvic Bones; Radiotherapy Dosage; Survival Rate | 1992 |
Rhabdomyosarcoma of the head and neck in children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Female; Head and Neck Neoplasms; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Netherlands; Prognosis; Retrospective Studies; Rhabdomyosarcoma; Treatment Outcome; Vincristine | 1992 |
Ewing's sarcoma: experience with 12 cases.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Sarcoma, Ewing; Vincristine | 1992 |
Primary rhabdomyosarcoma of the diaphragm. Report of a case presenting with hemothorax.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Diaphragm; Doxorubicin; Hemothorax; Humans; Ifosfamide; Male; Muscular Diseases; Rhabdomyosarcoma; Thoracotomy; Vincristine | 1992 |
Pancreatoblastoma: response to chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lymphatic Metastasis; Male; Pancreatic Neoplasms; Vinblastine; Vincristine | 1991 |
Long-term follow-up of ifosfamide renal toxicity in children treated for malignant mesenchymal tumors: an International Society of Pediatric Oncology report.
Topics: Acute Kidney Injury; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dactinomycin; Fanconi Syndrome; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kidney Diseases; Kidney Function Tests; Male; Sarcoma; Vincristine | 1991 |
[The importance of preoperative chemotherapy and radiotherapy in 373 children with Wilms' tumor].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Ifosfamide; Infant; Kidney Neoplasms; Male; Prognosis; Prospective Studies; Vincristine; Wilms Tumor | 1990 |
[Successful treatment of several metachronous pulmonary metastases of a chondroblastic osteosarcoma].
Topics: Amputation, Surgical; Bleomycin; Child; Chondroblastoma; Cyclophosphamide; Dactinomycin; Female; Humans; Ifosfamide; Leucovorin; Lung Neoplasms; Methotrexate; Osteosarcoma; Tibia | 1985 |
[Fibromatosis in children: regression with prolonged chemotherapy. Apropos of 2 cases].
Topics: Abdominal Muscles; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Dactinomycin; Fibroma; Humans; Ifosfamide; Male; Muscular Diseases; Radiography; Thorax; Vincristine | 1988 |
[Desmoid fibroma of the scapula. Recurrence with pulmonary metastasis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dactinomycin; Female; Fibroma; Humans; Ifosfamide; Lung Neoplasms; Neoplasm Recurrence, Local; Scapula; Tamoxifen; Vincristine | 1989 |
High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Neoplasm Recurrence, Local; Sarcoma, Ewing; Vincristine | 1989 |
The predictive value of initial cytostatic response in primary unresectable rhabdomyosarcoma in children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Ifosfamide; Neoplasm Staging; Prognosis; Rhabdomyosarcoma; Statistics as Topic; Vincristine | 1989 |
Anhydramnios and cessation of fetal growth in a pregnant mother with polychemotherapy during the second trimester.
Topics: Adult; Amniotic Fluid; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Facial Neoplasms; Female; Fetal Growth Retardation; Humans; Ifosfamide; Pregnancy; Pregnancy Complications, Neoplastic; Rhabdomyosarcoma; Vincristine | 1989 |
Correlation of an in vitro chemosensitivity test using [3H] incorporation with the response in case of human tumor chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Carbazilquinone; Colony-Forming Units Assay; Cytarabine; Dactinomycin; Doxorubicin; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Ifosfamide; Male; Mechlorethamine; Middle Aged; Mitomycin; Mitomycins; Nimustine; Nitrogen Mustard Compounds; Nitrosourea Compounds; Tritium; Tumor Stem Cell Assay | 1986 |
Irreversible encephalopathy with ifosfamide/mesna.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Child, Preschool; Dactinomycin; Female; Humans; Ifosfamide; Maxillary Neoplasms; Mercaptoethanol; Mesna; Rhabdomyosarcoma; Vincristine | 1987 |
[Objective response of desmoid fibroma to chemotherapy].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dactinomycin; Drug Tolerance; Fibroma; Humans; Ifosfamide; Knee Joint; Scapula; Vincristine | 1987 |
The role of ifosfamide in paediatric soft tissue sarcomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Dactinomycin; Drug Evaluation; Humans; Ifosfamide; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1986 |
Ifosfamide-induced renal tubular defect.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Ifosfamide; Infant; Infant, Newborn; Kidney Diseases; Male; Rhabdomyosarcoma; Urinary Bladder Neoplasms; Vincristine | 1994 |
Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Remission Induction; Salvage Therapy; Testicular Neoplasms; Transplantation, Autologous; Vinblastine | 1994 |
Osteosarcoma following radiation treatment for meningioma: report of a case and effective treatment with chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cisplatin; Dactinomycin; Etoposide; Female; Gonadotropin-Releasing Hormone; Humans; Ifosfamide; Lung Neoplasms; Meningeal Neoplasms; Meningioma; Methotrexate; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Osteosarcoma; Tamoxifen; Tomography, X-Ray Computed; Vincristine | 1994 |
[Extraosseous Ewing's sarcoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dactinomycin; Diagnosis, Differential; Doxorubicin; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Neoplasm Metastasis; Palliative Care; Radiotherapy Dosage; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 1995 |
Angiosarcoma of the breast and pregnancy: a new therapeutic approach.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dactinomycin; Female; Hemangiosarcoma; Humans; Ifosfamide; Mastectomy, Simple; Pregnancy; Pregnancy Complications, Neoplastic; Vincristine | 1995 |
A monocentric therapy study: an approach to optimize the results of the treatment of osteosarcoma by protocols based upon HDMTX, associated with systematic conservative surgery.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Clinical Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Follow-Up Studies; Humans; Ifosfamide; Leucovorin; Methotrexate; Middle Aged; Osteosarcoma; Pilot Projects; Remission Induction; Salvage Therapy; Treatment Outcome; Vincristine | 1993 |
Emesis induced in domestic pigs: a new experimental tool for detection of antiemetic drugs and for evaluation of emetogenic potential of new anticancer agents.
Topics: Animals; Antiemetics; Antineoplastic Agents; Carboplatin; Cisplatin; Cyclophosphamide; Dactinomycin; Disease Models, Animal; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Evaluation; Female; Ifosfamide; Infusions, Intravenous; Ketamine; Male; Metoclopramide; Serotonin Antagonists; Swine; Vomiting; Xylazine | 1994 |
B19 parvovirus infection in children with malignant solid tumors receiving chemotherapy.
Topics: Acute Disease; Adolescent; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child, Preschool; Cyclophosphamide; Dactinomycin; Erythema Infectiosum; Female; Humans; Ifosfamide; Immunocompromised Host; Parvovirus B19, Human; Rhabdomyosarcoma; Vincristine | 1994 |
Lung irradiation for Ewing's sarcoma with pulmonary metastases at diagnosis: results of the CESS-studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Germany; Humans; Ifosfamide; Lung Neoplasms; Radiotherapy Dosage; Sarcoma, Ewing; Vincristine | 1993 |
Ewing's sarcoma: evaluation of chemotherapy in 17 cases.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Ifosfamide; Male; Prognosis; Radiography; Sarcoma, Ewing; Vincristine | 1993 |
[Intensive chemotherapy for alveolar soft part sarcoma with lung metastasis in a child].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Male; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1993 |
Chemotherapy in the management of infantile fibrosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Fibrosarcoma; Humans; Ifosfamide; Infant; Infant, Newborn; Karyotyping; Leg; Male; Remission Induction; Soft Tissue Neoplasms; Treatment Outcome; Vincristine | 1993 |
[Pathology and clinical aspects of peripheral neuroectodermal tumors].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Fatal Outcome; Humans; Ifosfamide; Lung Neoplasms; Male; Neuroectodermal Tumors, Primitive, Peripheral; Neurofilament Proteins; Pancoast Syndrome; Vincristine | 1993 |
[Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patients treated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin, cyclophosphamide, dactinomycin, ifosfamide and etoposide)].
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Radiotherapy Dosage; Sarcoma, Ewing; Vincristine | 1995 |
Hepatic angiosarcoma in a child: successful therapy with surgery and adjuvant chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hemangiosarcoma; Humans; Ifosfamide; Liver Neoplasms; Vincristine | 1997 |
Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Chlorambucil; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome; Vinblastine | 1997 |
Successful treatment of orbital rhabdomyosarcoma in two infants using chemotherapy alone.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dactinomycin; Doxorubicin; Female; Humans; Ifosfamide; Male; Orbital Neoplasms; Rhabdomyosarcoma; Vincristine | 1997 |
"Response to Hord and Janco re chemotherapy for unresectable pancreatoblastoma".
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Dactinomycin; Drug Resistance, Neoplasm; Fatal Outcome; Follow-Up Studies; Humans; Ifosfamide; Male; Pancreatic Neoplasms; Vincristine | 1997 |
[The type of local treatment conditions the prognosis in patients with nonmetastatic Ewing's sarcoma of the extremities treated with adjuvant chemotherapy].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arm; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leg; Male; Neoplasm Recurrence, Local; Prognosis; Radiotherapy, Adjuvant; Sarcoma, Ewing; Vincristine | 1997 |
Abdominal irradiation in unilateral nephroblastoma and its impact on local control and survival.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Doxorubicin; Follow-Up Studies; Humans; Ifosfamide; Infant; Kidney Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Vincristine; Wilms Tumor | 1998 |
Double high-dose chemotherapy with autologous peripheral stem cell rescue in relapsed Wilms' tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Dactinomycin; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Kidney Neoplasms; Lung Neoplasms; Salvage Therapy; Vincristine; Wilms Tumor | 1997 |
Rhabdomyosarcoma of extrahepatic biliary tree: initial treatment with chemotherapy and conservative surgery.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Child, Preschool; Dactinomycin; Female; Humans; Ifosfamide; Rhabdomyosarcoma; Vincristine | 1998 |
[Peripheral neuroectodermal tumors of the chest wall. Description of a case].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dactinomycin; Fatal Outcome; Female; Humans; Ifosfamide; Lung Neoplasms; Neuroectodermal Tumors, Primitive, Peripheral; Thoracic Neoplasms; Vincristine | 1998 |
Toxicity of chemotherapeutical protocols in the treatment of uterine sarcomas (Vincristine, actinomycin D, Cyclophosphamide VAC versus ifosfamide).
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Dactinomycin; Female; Humans; Ifosfamide; Middle Aged; Sarcoma; Uterine Neoplasms; Vincristine | 1998 |
[Drug-resistant genito-urinary rhabdomyosarcoma in children with primary psoas abscess. Apropos of a case].
Topics: Adolescent; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dactinomycin; Drug Resistance, Neoplasm; Epirubicin; Humans; Ifosfamide; Male; Pelvic Neoplasms; Psoas Abscess; Rhabdomyosarcoma, Embryonal; Vincristine | 1997 |
Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms, Second Primary; Radiotherapy Dosage; Sarcoma; Sarcoma, Ewing; Time Factors; Vincristine | 1998 |
Predictive factors of histological response to primary chemotherapy in Ewing's sarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Neoplasm Staging; Predictive Value of Tests; Sarcoma, Ewing; Vincristine | 1998 |
Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue. A feasibility study.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Radiotherapy Dosage; Retrospective Studies; Salvage Therapy; Sarcoma; Treatment Failure; Vincristine; Whole-Body Irradiation | 1999 |
Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Italy; L-Lactate Dehydrogenase; Male; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Retrospective Studies; Sarcoma, Ewing; Vincristine | 2000 |
Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcoma. United Kingdom Children's Cancer Study Group (UKCCSG).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Sarcoma, Ewing; Treatment Outcome; Vincristine | 1999 |
Assessment of systemic toxicity in children receiving chemotherapy with cyclosporine for sarcoma.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Transfusion; Chi-Square Distribution; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Dactinomycin; Etoposide; Female; Fever; Humans; Ifosfamide; Male; Neutropenia; Pilot Projects; Platelet Transfusion; Retrospective Studies; Sarcoma; Sepsis; Treatment Outcome; Vincristine | 2000 |
Desmoplastic small round cell tumour in children and adolescents.
Topics: Abdominal Neoplasms; Adolescent; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Salvage Therapy; Sarcoma, Small Cell; Survival Rate; Testicular Neoplasms; Vincristine | 2000 |
Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT).
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dactinomycin; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Male; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Teratoma; Testicular Neoplasms; Treatment Outcome; Vinblastine; Vincristine | 2000 |
Rhabdomyosarcoma of the corpus of the uterus: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Female; Humans; Hysterectomy; Ifosfamide; Rhabdomyosarcoma; Uterine Neoplasms; Vincristine | 2000 |
Selective use of whole-lung irradiation for patients with Ewing sarcoma family tumors and pulmonary metastases at the time of diagnosis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Dose Fractionation, Radiation; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Life Tables; Lung Neoplasms; Male; Radiation Pneumonitis; Radiotherapy; Remission Induction; Retrospective Studies; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Ifosfamide; Infant; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Risk Factors; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation.
Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Catechols; Child; Chromosome Breakage; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 4; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Etoposide; Female; Histone-Lysine N-Methyltransferase; Humans; Ifosfamide; Isoenzymes; Models, Genetic; Molecular Sequence Data; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasms, Second Primary; Nuclear Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogenes; Radiotherapy, Adjuvant; Recombination, Genetic; Rhabdomyosarcoma, Alveolar; Soft Tissue Neoplasms; Transcription Factors; Transcriptional Elongation Factors; Translocation, Genetic; Vincristine | 2001 |
Serum creatine kinase levels parallel the clinical course for rhabdomyomatous Wilms tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Creatine Kinase; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Infant; Kidney Neoplasms; Mesna; Neoplasm Recurrence, Local; Nephrectomy; Reference Standards; Rhabdomyoma; Vincristine; Wilms Tumor | 2001 |
Pleuropulmonary blastoma.
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Child, Preschool; Dactinomycin; Disease-Free Survival; Humans; Ifosfamide; Lung Neoplasms; Male; Pleural Neoplasms; Pneumonectomy; Pulmonary Blastoma; Vincristine | 2001 |
Rhabdomyosarcoma of the hand.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Dactinomycin; Female; Hand; Humans; Ifosfamide; Prognosis; Rhabdomyosarcoma, Alveolar; Treatment Outcome; Vincristine | 2001 |
[Treatment of Ewing's sarcoma with 2 different protocols].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Ifosfamide; Male; Prognosis; Radiotherapy; Sarcoma, Ewing; Survival Rate; Vincristine | 2001 |
Postoperative radiotherapy in the treatment of Ewing tumors: influence of the interval between surgery and radiotherapy.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Data Interpretation, Statistical; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Pilot Projects; Postoperative Care; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Survival Analysis; Time Factors; Vincristine | 2002 |
Response to chemotherapy in a child with primary bronchopulmonary leiomyosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Child, Preschool; Dactinomycin; Doxorubicin; Humans; Ifosfamide; Leiomyosarcoma; Lung Neoplasms; Male; Time Factors; Treatment Outcome; Vincristine | 2002 |
[Pediatric rhabdomyosarcoma of the infratemporal fossa].
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Ifosfamide; Infant; Lymphatic Metastasis; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Radiotherapy Dosage; Rhabdomyosarcoma; Survival Analysis; Time Factors; Vincristine | 2002 |
Management of alveolar rhabdomyosarcoma of the orbit.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dactinomycin; Doxorubicin; Female; Humans; Ifosfamide; Infant; Magnetic Resonance Imaging; Ophthalmologic Surgical Procedures; Orbital Neoplasms; Rhabdomyosarcoma, Alveolar; Vincristine | 2002 |
Regression of refractory rhabdomyosarcoma after allogeneic stem-cell transplantation.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Female; Graft vs Tumor Effect; Head and Neck Neoplasms; Humans; Ifosfamide; Immunosuppressive Agents; Neoplasm Recurrence, Local; Nimustine; Peripheral Blood Stem Cell Transplantation; Rhabdomyosarcoma; Transplantation Conditioning; Vincristine | 2003 |
Chemotherapy alone for the treatment of congenital fibrosarcoma: is surgery always needed?
Topics: Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Fibrosarcoma; Hand; Humans; Ifosfamide; Infant; Magnetic Resonance Imaging; Male; Treatment Outcome; Vincristine | 2003 |
Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Humans; Ifosfamide; Infant; Lymph Node Excision; Male; Mesenchymoma; Neoplasm Recurrence, Local; Neoplasm Staging; Rhabdomyosarcoma; Salvage Therapy; Survival Rate; Testicular Neoplasms; Treatment Outcome; Vincristine | 2003 |
Peripheral medulloepithelioma: an immunohistochemical, ultrastructural, and cytogenetic study of a rare, chemotherapy-sensitive, pediatric tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 8; Cyclophosphamide; Dactinomycin; Desmosomes; Disease-Free Survival; Doxorubicin; Female; Humans; Ifosfamide; Immunohistochemistry; Neoplasm Proteins; Neuroectodermal Tumors, Primitive; Pelvic Neoplasms; Remission Induction; Spectral Karyotyping; Treatment Outcome; Trisomy; Vincristine | 2003 |
Anaplastic (pleomorphic) subtype embryonal rhabdomyosarcoma of the cervix.
Topics: Adolescent; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemotherapy, Adjuvant; Dactinomycin; Female; Gynecologic Surgical Procedures; Humans; Ifosfamide; Rhabdomyosarcoma, Embryonal; Treatment Outcome; Uterine Cervical Neoplasms; Vincristine | 2004 |
Hemopoietic recovery and infectious complications in breast cancer and multiple myeloma after autologous CD34+ cell-selected peripheral blood progenitor cell transplantation.
Topics: Adult; Aged; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Graft Survival; Hematopoiesis; Humans; Idarubicin; Ifosfamide; Infections; Male; Middle Aged; Multiple Myeloma; Neutropenia; Peripheral Blood Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine; Whole-Body Irradiation | 2004 |
Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neuroectodermal Tumors, Primitive, Peripheral; Prognosis; Radiotherapy Dosage; Retrospective Studies; Sarcoma, Ewing; Treatment Failure; Vincristine | 2004 |
Spinal cord compression and lung metastasis of Wilms' tumor in a pregnant adolescent.
Topics: Abdominal Pain; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Dexamethasone; Etoposide; Female; Fetus; Humans; Ifosfamide; Infant, Newborn; Kidney Neoplasms; Lumbar Vertebrae; Lung Neoplasms; Neoplasm Recurrence, Local; Patient Dropouts; Polyradiculopathy; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Spinal Cord Compression; Vincristine; Wilms Tumor | 2004 |
[Alveolar rhabdomyosarcoma originating in spermatic cord: a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dactinomycin; Drug Administration Schedule; Genital Neoplasms, Male; Humans; Ifosfamide; Male; Orchiectomy; Rhabdomyosarcoma, Alveolar; Spermatic Cord; Vincristine | 2004 |
[A case of retroperitoneal neuroblastoma in an adult with extensive bone marrow metastasis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Carboplatin; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Male; Neuroblastoma; Paraplegia; Retroperitoneal Neoplasms; Skull Neoplasms; Vincristine | 2004 |
Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: local outcome and prognostic factors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Sarcoma, Ewing; Survival Rate; Treatment Outcome; Vincristine | 2005 |
A case of primary botryoid conjunctival rhabdomyosarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Combined Modality Therapy; Conjunctival Neoplasms; Dactinomycin; Dose Fractionation, Radiation; Female; Humans; Ifosfamide; Ophthalmologic Surgical Procedures; Rhabdomyosarcoma; Vincristine | 2006 |
Prognostic factors in pleuro-pulmonary blastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasm Staging; Pleural Neoplasms; Pneumonectomy; Prognosis; Pulmonary Blastoma; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Second-Look Surgery; Treatment Outcome; Vincristine | 2007 |
[Long-term experiences in the therapy of esthesioneuroblastoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Dactinomycin; Doxorubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Nasal Cavity; Neoplasm Staging; Nose Neoplasms; Prognosis; Radiotherapy Dosage; Retrospective Studies; Survival Analysis; Time Factors; Vincristine | 2006 |
Detection of chemotherapy-induced enterocyte toxicity with circulating intestinal fatty acid binding protein.
Topics: Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Biomarkers; Child, Preschool; Dactinomycin; Diarrhea; Enterocytes; Fatty Acid-Binding Proteins; Female; Humans; Ifosfamide; Rhabdomyosarcoma; Treatment Outcome; Vincristine | 2006 |
Dose response and local control using radiotherapy in non-metastatic Ewing sarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Radiotherapy Dosage; Radiotherapy, High-Energy; Retrospective Studies; Sarcoma, Ewing; Treatment Outcome; United States; Vincristine | 2007 |
[Acquired Fanconi-de Toni-Debre syndrome due to therapy for Ewing's sarcoma in 5-years old boy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child, Preschool; Dactinomycin; Doxorubicin; Etoposide; Fanconi Syndrome; Femur; Humans; Ifosfamide; Male; Sarcoma, Ewing; Vincristine | 2006 |
Primary rhabdomyosarcoma of the breast in a 13-year-old girl: report of a case.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Dactinomycin; Doxorubicin; Fatal Outcome; Female; Humans; Ifosfamide; Lung Neoplasms; Mastectomy; Rhabdomyosarcoma, Alveolar | 2007 |
[A case of the treatment in an adult with hepatic undifferentiated (embryonal) sarcoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Doxorubicin; Female; Humans; Ifosfamide; Liver Neoplasms; Middle Aged; Sarcoma; Tomography, X-Ray Computed; Vincristine | 2007 |
Thyroid function in paediatric and young adult patients after sarcoma therapy: a report from the Late Effects Surveillance System.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Dactinomycin; Female; Follow-Up Studies; Humans; Ifosfamide; Incidence; Male; Multivariate Analysis; Sarcoma; Thyroid Diseases; Thyroid Function Tests; Thyroid Gland; Thyrotropin; Thyroxine; Vincristine | 2007 |
Ewing's sarcoma and primitive neuroectodermal tumour in adults: single-centre experience in The Netherlands.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Netherlands; Neuroectodermal Tumors, Primitive, Peripheral; Retrospective Studies; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine | 2007 |
Renal failure does not preclude cure in children receiving chemotherapy for Wilms tumor: a report from the National Wilms Tumor Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Dactinomycin; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Kidney Neoplasms; Male; Renal Insufficiency; Treatment Outcome; Vincristine; Wilms Tumor | 2008 |
[Preoperative adjuvant therapy for primary malignant bone tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Humans; Ifosfamide; Neoadjuvant Therapy; Neoplasm Metastasis; Osteosarcoma; Prognosis; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 2007 |
Childhood papillary thyroid cancer as second malignancy after successful treatment of rhabdomyosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Papillary; Combined Modality Therapy; Dactinomycin; DNA, Neoplasm; Epirubicin; Etoposide; Humans; Ifosfamide; Infant; Iodine Radioisotopes; Male; Neoplasms, Second Primary; Rhabdomyosarcoma, Embryonal; Spinal Neoplasms; Thoracic Vertebrae; Thyroid Neoplasms; Thyroidectomy; Vincristine | 2008 |
Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with Wilms tumour.
Topics: Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Glomerular Filtration Rate; Humans; Ifosfamide; Infant; Kidney Neoplasms; Kidney Tubules; Linear Models; Male; Nephrectomy; Prospective Studies; Treatment Outcome; Vincristine; Wilms Tumor | 2009 |
Secondary leukemia in a child conceived using in vitro fertilization.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child, Preschool; Cyclophosphamide; Dactinomycin; Etoposide; Fertilization in Vitro; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Radiotherapy, Adjuvant; Rhabdomyosarcoma; Vincristine | 2008 |
Extra-osseous Ewing sarcoma.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Child; Child, Preschool; Dactinomycin; Female; Follow-Up Studies; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Prognosis; Protein Synthesis Inhibitors; Sarcoma, Ewing; Treatment Outcome; Vincristine | 2009 |
Local and systemic control of Ewing's bone sarcoma family tumors of the ribs.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bone Plates; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Fascia Lata; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Retrospective Studies; Ribs; Sarcoma, Ewing; Surgical Mesh; Thoracotomy; Vincristine | 2009 |
Radiation toxicity following busulfan/melphalan high-dose chemotherapy in the EURO-EWING-99-trial: review of GPOH data.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Busulfan; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Cross-Sectional Studies; Dactinomycin; Dose-Response Relationship, Drug; Germany; Humans; Ifosfamide; Intestines; Lung; Melphalan; Multicenter Studies as Topic; Radiation Injuries; Radiotherapy Dosage; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Registries; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Spinal Cord; Survivors; Vincristine | 2009 |
Alveolar rhabdomyosarcoma of the extremity and nodal metastasis: Is the in-transit lymphatic system at risk?
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Camptothecin; Child; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Etoposide; Fatal Outcome; Female; Foot; Groin; Humans; Ifosfamide; Irinotecan; Lymph Node Excision; Lymphatic Metastasis; Lymphatic System; Male; Niacinamide; Phenylurea Compounds; Pyridines; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Rhabdomyosarcoma, Alveolar; Salvage Therapy; Soft Tissue Neoplasms; Sorafenib; Temozolomide; Thigh; Vincristine | 2009 |
Undifferentiated sarcoma of the thyroid in a child.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dactinomycin; Doxorubicin; Female; Humans; Ifosfamide; Immunohistochemistry; Radiotherapy; Sarcoma; Thyroid Neoplasms; Thyroidectomy; Vincristine | 2010 |
[Case report of a 2-year-old child with palpebral rhabdomyosarcoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Blepharoptosis; Child, Preschool; Combined Modality Therapy; Dactinomycin; Eyelid Neoplasms; Hematoma; Humans; Ifosfamide; Male; Radiotherapy, Adjuvant; Remission Induction; Rhabdomyosarcoma, Embryonal; Vincristine | 2010 |
[A rare tumour with a distinctive histological appearance].
Topics: Adolescent; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Arteriovenous Malformations; Bevacizumab; Biomarkers, Tumor; Combined Modality Therapy; Dactinomycin; Desmin; Diagnosis, Differential; Dioxoles; Doxorubicin; Humans; Ifosfamide; Leg; Lung Neoplasms; Male; Neoplasm Proteins; Prognosis; S100 Proteins; Sarcoma, Alveolar Soft Part; Soft Tissue Neoplasms; Staining and Labeling; Tetrahydroisoquinolines; Trabectedin; Vincristine | 2010 |
Extraskeletal Ewing's sarcoma family of tumours in adults: analysis of 57 patients from a single institution.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Doxorubicin; Humans; Ifosfamide; Kaplan-Meier Estimate; Middle Aged; Radiotherapy; Sarcoma; Sarcoma, Ewing; Vincristine; Young Adult | 2010 |
Infratentorial brain metastases of pediatric non-epithelial malignant tumors: three case reports.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Infratentorial Neoplasms; Irinotecan; Melphalan; Neoplasm Metastasis; Neuroblastoma; Rhabdomyosarcoma; Thiotepa; Topotecan; Vincristine | 2011 |
Characterisation of transient benign hCG elevations in women following chemotherapy for GTT.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Dactinomycin; Estradiol; Etoposide; Female; Follicle Stimulating Hormone; Gestational Trophoblastic Disease; Humans; Ifosfamide; Leucovorin; Luteinizing Hormone; Methotrexate; Pregnancy; Retrospective Studies; Taxoids; Vincristine; Young Adult | 2011 |
Treatment outcome of Korean patients with localized Ewing sarcoma family of tumors: a single institution experience.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Confounding Factors, Epidemiologic; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Odds Ratio; Prognosis; Republic of Korea; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Time Factors; Treatment Outcome; Vincristine; Young Adult | 2011 |
[Primitive cutaneous Ewing's sarcoma: a diagnostic and therapeutic dilemma].
Topics: 12E7 Antigen; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Calmodulin-Binding Proteins; Cell Adhesion Molecules; Chemotherapy, Adjuvant; Combined Modality Therapy; Dactinomycin; Disease Management; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; In Situ Hybridization, Fluorescence; Neoplasm Proteins; Reoperation; RNA-Binding Protein EWS; RNA-Binding Proteins; Sarcoma, Ewing; Shoulder; Skin Neoplasms; Vincristine; Young Adult | 2011 |
Patterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
Topics: Adolescent; Age Factors; Anemia; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Female; Humans; Ifosfamide; Incidence; Male; Mesna; Neutropenia; Rhabdomyosarcoma; Sex Characteristics; Survival Rate; Thrombocytopenia; Vincristine; Young Adult | 2012 |
Teratoid Wilms' tumor: case report of a rare variant that can mimic aggressive biology during chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dactinomycin; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Ifosfamide; Infant; Kidney Neoplasms; Male; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Nephrectomy; Prognosis; Stromal Cells; Vincristine; Wilms Tumor | 2011 |
Persistent elevation of fetal hemoglobin following chemotherapy in sickle cell disease.
Topics: Anemia, Sickle Cell; Antineoplastic Combined Chemotherapy Protocols; Child; Dactinomycin; Doxorubicin; Female; Fetal Hemoglobin; Humans; Ifosfamide; Vincristine; Wilms Tumor | 2012 |
Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Incidence; L-Lactate Dehydrogenase; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine | 2012 |
Regression of mesenchymal hamartoma of the liver with sarcoma chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Diagnostic Errors; Doxorubicin; Etoposide; Female; Hamartoma; Humans; Ifosfamide; Liver Neoplasms; Mesoderm; Prognosis; Sarcoma, Ewing; Vincristine; Young Adult | 2013 |
Case report: stimulation of puberty in a girl with chemo- and radiation therapy induced ovarian failure by transplantation of a small part of her frozen/thawed ovarian tissue.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cryopreservation; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Fertility Preservation; Follicle Stimulating Hormone; Humans; Ifosfamide; Ovary; Primary Ovarian Insufficiency; Prognosis; Puberty; Radiotherapy, Conformal; Sarcoma, Ewing; Vincristine | 2013 |
Spindle cell rhabdomyosarcoma of the prostate.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Doxorubicin; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Prostate; Prostatic Neoplasms; Rhabdomyosarcoma; Sarcoma; Vincristine; Young Adult | 2013 |
Embryonal sarcoma of the liver.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Doxorubicin; Epirubicin; Female; Humans; Ifosfamide; Infant; Liver; Liver Neoplasms; Male; Retrospective Studies; Sarcoma; Survival Analysis; Treatment Outcome; Vincristine | 2013 |
Diagnosis and treatment of lymph node metastases in pediatric rhabdomyosarcoma in the Netherlands: a retrospective analysis.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brachytherapy; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Lymph Node Excision; Lymphatic Irradiation; Lymphatic Metastasis; Male; Neoplasm Staging; Netherlands; Proportional Hazards Models; Recurrence; Retrospective Studies; Rhabdomyosarcoma; Sensitivity and Specificity; Survival Rate; Treatment Outcome; Vincristine | 2014 |
All children with malignant rhabdoid tumors should be treated initially with intensive chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Male; Mediastinal Neoplasms; Rhabdoid Tumor; Tomography, X-Ray Computed; Vincristine | 2015 |
Validation of a multi-modal treatment protocol for Ewing sarcoma--a report from the polish pediatric oncology group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Feasibility Studies; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Infant, Newborn; Lung Neoplasms; Male; Neoplasm Staging; Pediatrics; Poland; Postoperative Complications; Prognosis; Radiotherapy Dosage; Sarcoma, Ewing; Survival Rate; Vincristine; Young Adult | 2014 |
Orbital rhabdomyosarcoma in children: a favorable primary suitable for a less-invasive treatment strategy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Epirubicin; Follow-Up Studies; Humans; Ifosfamide; Infant; Neoplasm Staging; Orbital Neoplasms; Prognosis; Radionuclide Imaging; Retrospective Studies; Rhabdomyosarcoma; Treatment Outcome; Vincristine; Young Adult | 2014 |
Developing a prognostic model for localized Ewing sarcoma family of tumors: A single institutional experience of 224 cases treated with uniform chemotherapy protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Leukocyte Count; Male; Neoadjuvant Therapy; Prognosis; Radiotherapy, Adjuvant; Sarcoma, Ewing; Vincristine | 2015 |
PARP Inhibitors Sensitize Ewing Sarcoma Cells to Temozolomide-Induced Apoptosis via the Mitochondrial Pathway.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Dacarbazine; Dactinomycin; Doxorubicin; Drug Synergism; Etoposide; G2 Phase Cell Cycle Checkpoints; Humans; Ifosfamide; Metabolic Networks and Pathways; Mitochondria; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Sarcoma, Ewing; Temozolomide; Vincristine | 2015 |
Treatment outcomes of Japanese patients with Ewing sarcoma: differences between skeletal and extraskeletal Ewing sarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asian People; Bone Neoplasms; Child; Child, Preschool; Dactinomycin; Doxorubicin; Female; Humans; Ifosfamide; Infant; Japan; Lower Extremity; Male; Middle Aged; Multivariate Analysis; Prognosis; Retrospective Studies; Sarcoma, Ewing; Survival Rate; Treatment Outcome; Upper Extremity; Vincristine; Young Adult | 2016 |
Type III pleuropulmonary blastoma in a dicer1 germline mutation carrier: The management of residual lung cystic lesions.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cysts; Dactinomycin; DEAD-box RNA Helicases; Doxorubicin; Germ-Line Mutation; Heterozygote; Humans; Ifosfamide; Lung Diseases; Male; Pulmonary Blastoma; Ribonuclease III; Vincristine | 2017 |
Extra-Adrenal Adult Neuroblastoma With Aberrant Germ Cell Marker Expression: Maturation After Chemotherapy as an Important Clue to a Challenging Diagnosis.
Topics: Abdominal Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemoradiotherapy; Cyclophosphamide; Dactinomycin; Diagnosis, Differential; Etoposide; Germ Cells; Homeobox Protein Nkx-2.2; Homeodomain Proteins; Humans; Ifosfamide; Inguinal Canal; Male; Neuroblastoma; Nuclear Proteins; Octamer Transcription Factor-3; Transcription Factors; Vincristine | 2019 |
Tumour expressions of hypoxic markers predict the response to neo-adjuvant chemotherapy in children with inoperable rhabdomyosarcoma.
Topics: Adolescent; Antigens, Neoplasm; Biomarkers, Tumor; Biopsy; Carbonic Anhydrase IX; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Dactinomycin; Epirubicin; Female; Gene Expression; Glucose Transporter Type 1; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Ifosfamide; Infant; Infant, Newborn; Male; Muscle Neoplasms; Neoadjuvant Therapy; Prognosis; Prospective Studies; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Survival Analysis; Treatment Outcome; Vascular Endothelial Growth Factor A; Vincristine | 2019 |
Rhabdomyosarcoma in adults: analysis of treatment modalities in a prospective single-center series.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Prospective Studies; Rhabdomyosarcoma; Survival Rate; Vincristine; Young Adult | 2019 |
Primary cutaneous alveolar rhabdomyosarcoma in an adolescent - A challenging diagnosis.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Humans; Ifosfamide; Male; Positron-Emission Tomography; Rhabdomyosarcoma, Alveolar; Skin Neoplasms; Vincristine | 2020 |
Epithelioid Hyalinizing Sarcoma With MGA-NUTM1 Fusion.
Topics: Antineoplastic Combined Chemotherapy Protocols; Basic Helix-Loop-Helix Transcription Factors; Cyclophosphamide; Dactinomycin; Etoposide; Foot; Foot Bones; Gene Fusion; Humans; Hyalin; Ifosfamide; Magnetic Resonance Imaging; Male; Middle Aged; Muscle, Skeletal; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Nuclear Proteins; Organophosphorus Compounds; Sarcoma; Vincristine | 2020 |
VIVA (vinorelbine, ifosfamide, vincristine, actinomycin-D): A new regimen in the armamentarium of systemic therapy for high-risk rhabdomyosarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dactinomycin; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Prognosis; Rhabdomyosarcoma; Risk Factors; Vincristine; Vinorelbine | 2020 |
Embryonal rhabdomyosarcoma completely resected at diagnosis: The European paediatric Soft tissue sarcoma Study Group RMS2005 experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Prognosis; Prospective Studies; Retrospective Studies; Rhabdomyosarcoma, Embryonal; Risk Factors; Survival Rate; Vincristine | 2021 |
Multiagent chemotherapy including IrIVA regimen and maintenance therapy in the treatment of desmoplastic small round cell tumor.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Dactinomycin; Desmoplastic Small Round Cell Tumor; Dose-Response Relationship, Drug; Doxorubicin; Humans; Ifosfamide; Irinotecan; Male; Treatment Outcome; Vincristine; Vinorelbine; Young Adult | 2022 |
Multimodality treatment including whole pleura radiation therapy for DICER1-associated pediatric pleuropulmonary blastoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Combined Modality Therapy; Dactinomycin; DEAD-box RNA Helicases; Doxorubicin; Female; Frameshift Mutation; Humans; Ifosfamide; Lung Neoplasms; Pulmonary Blastoma; Radiotherapy, Conformal; Ribonuclease III; Vincristine | 2021 |
Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only - the SIOP 93-01 and 2001 protocols.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Vincristine; Wilms Tumor | 2022 |